Cosmos Health (COSM) FCF Margin (2014 - 2026)
Cosmos Health (COSM) recorded quarterly FCF Margin of 6.02% in Q1 2026, down 157.32% on a QoQ basis from 10.5% in Q4 2025, and down 457.0% year-over-year from 1.69% in Q1 2025.
Cosmos Health (COSM) FCF Margin (2014 - 2026) Analysis & Trends
Cosmos Health has disclosed FCF Margin across 12 years of filings, most recently posting 6.02% for Q1 2026.
- Quarterly FCF Margin fell 457.0% year-over-year to 6.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 158.62% (down 14958.0% YoY) and the FY2025 annual result came in at 500.19%, down 48525.0% from the prior year.
- FCF Margin eased to 6.02% in Q1 2026, from 10.5% in the prior quarter.
- Over five years, FCF Margin peaked at 10.5% in Q4 2025 and troughed at 85.93% in Q4 2022.
- A 5-year average of 19.76% and a median of 12.77% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 7599 bps — and 2023, when it surged 9164 bps.
- Tracing COSM's FCF Margin over 5 years: stood at 85.93% in 2022, then jumped by 107 bps to 5.71% in 2023, then sank by 581 bps to 27.46% in 2024, then jumped by 138 bps to 10.5% in 2025, then slumped by 157 bps to 6.02% in 2026.
- Business Quant data shows COSM's FCF Margin at 6.02% in Q1 2026, 10.5% in Q4 2025, and 14.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 3.48% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.50% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 2.75% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -3.62% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -19.45% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -18.96% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 1.06% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -6.02% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.02% |
| Dec 31, 2025 | 10.50% |
| Sep 30, 2025 | -14.42% |
| Jun 30, 2025 | -8.36% |
| Mar 31, 2025 | -1.45% |
| Dec 31, 2024 | -27.46% |
| Sep 30, 2024 | 4.12% |
| Jun 30, 2024 | -9.43% |
| Mar 31, 2024 | -23.96% |
| Dec 31, 2023 | 5.71% |
| Sep 30, 2023 | -35.40% |
| Jun 30, 2023 | -56.16% |
| Mar 31, 2023 | -51.58% |
| Dec 31, 2022 | -85.93% |
| Sep 30, 2022 | -12.77% |
| Jun 30, 2022 | -5.40% |
| Mar 31, 2022 | -17.91% |
| Dec 31, 2021 | -9.94% |
| Sep 30, 2021 | -26.03% |
| Jun 30, 2021 | -12.55% |